This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verardi, P. H.
Right arrow Articles by Yilma, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verardi, P. H.
Right arrow Articles by Yilma, T. D.

 Previous Article  |  Next Article 

Journal of Virology, January 2001, p. 11-18, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.11-18.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Vaccinia Virus Vectors with an Inactivated Gamma Interferon Receptor Homolog Gene (B8R) Are Attenuated In Vivo without a Concomitant Reduction in Immunogenicity

Paulo H. Verardi, Leslie A. Jones, Fatema H. Aziz, Shabbir Ahmad, and Tilahun D. Yilma*

International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California 95616

Received 23 August 2000/Accepted 3 October 2000

The vaccinia virus (VV) B8R gene encodes a secreted protein with homology to the gamma interferon (IFN-gamma ) receptor. In vitro, the B8R protein binds to and neutralizes the antiviral activity of several species of IFN-gamma , including human and rat IFN-gamma ; it does not, however, bind significantly to murine IFN-gamma . Here we report on the construction and characterization of recombinant VVs (rVVs) lacking the B8R gene. While the deletion of this gene had no effect on virus replication in vitro, rVVs lacking the B8R gene were attenuated for mice. There was a significant decrease in weight loss and mortality in normal mice, and nude mice survived significantly longer than did controls inoculated with parental virus. This is a surprising result considering the minimal binding of the B8R protein to murine IFN-gamma and its failure to block the antiviral activity of this cytokine in vitro. Such reduction in virulence could not be determined in rats, since they are considerably more resistant to VV infection than are mice. Finally, deletion of the B8R gene had no detectable effects on humoral immune responses. Mice and rats vaccinated with the rVVs showed identical humoral responses to both homologous and heterologous genes expressed by VV. This study demonstrates that the deletion of the VV B8R gene leads to enhanced safety without a concomitant reduction in immunogenicity.


* Corresponding author. Mailing address: International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616. Phone: (530) 752-8306. Fax: (530) 752-1354. E-mail: tdyilma{at}ucdavis.edu.


Journal of Virology, January 2001, p. 11-18, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.11-18.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Trilling, M., Le, V. T. K., Zimmermann, A., Ludwig, H., Pfeffer, K., Sutter, G., Smith, G. L., Hengel, H. (2009). Gamma Interferon-Induced Interferon Regulatory Factor 1-Dependent Antiviral Response Inhibits Vaccinia Virus Replication in Mouse but Not Human Fibroblasts. J. Virol. 83: 3684-3695 [Abstract] [Full Text]  
  • Peng, Y., Lin, F.-c., Verardi, P. H., Jones, L. A., Yilma, T. D. (2009). Lower Levels of Gamma Interferon Expressed by a Pseudotyped Single-Cycle Simian Immunodeficiency Virus Enhance Immunogenicity in Rats. J. Virol. 83: 1592-1601 [Abstract] [Full Text]  
  • Day, S. L., Ramshaw, I. A., Ramsay, A. J., Ranasinghe, C. (2008). Differential Effects of the Type I Interferons {alpha}4, {beta}, and {epsilon} on Antiviral Activity and Vaccine Efficacy. J. Immunol. 180: 7158-7166 [Abstract] [Full Text]  
  • Sakala, I. G., Chaudhri, G., Buller, R. M., Nuara, A. A., Bai, H., Chen, N., Karupiah, G. (2007). Poxvirus-Encoded Gamma Interferon Binding Protein Dampens the Host Immune Response to Infection. J. Virol. 81: 3346-3353 [Abstract] [Full Text]  
  • Ahmed, C. M., Martin, J. P., Johnson, H. M. (2007). IFN Mimetic as a Therapeutic for Lethal Vaccinia Virus Infection: Possible Effects on Innate and Adaptive Immune Responses. J. Immunol. 178: 4576-4583 [Abstract] [Full Text]  
  • Nuara, A. A., Buller, R. M. L., Bai, H. (2007). Identification of residues in the ectromelia virus gamma interferon-binding protein involved in expanded species specificity. J. Gen. Virol. 88: 51-60 [Abstract] [Full Text]  
  • Chan, K. S., Verardi, P. H., Legrand, F. A., Yilma, T. D. (2005). Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus. Proc. Natl. Acad. Sci. USA 102: 8734-8739 [Abstract] [Full Text]  
  • Jackson, S. S., Ilyinskii, P., Philippon, V., Gritz, L., Yafal, A. G., Zinnack, K., Beaudry, K. R., Manson, K. H., Lifton, M. A., Kuroda, M. J., Letvin, N. L., Mazzara, G. P., Panicali, D. L. (2005). Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus. J. Virol. 79: 6554-6559 [Abstract] [Full Text]  
  • Ahmed, C. M. I., Burkhart, M. A., Subramaniam, P. S., Mujtaba, M. G., Johnson, H. M. (2005). Peptide Mimetics of Gamma Interferon Possess Antiviral Properties against Vaccinia Virus and Other Viruses in the Presence of Poxvirus B8R Protein. J. Virol. 79: 5632-5639 [Abstract] [Full Text]  
  • Legrand, F. A., Verardi, P. H., Chan, K. S., Peng, Y., Jones, L. A., Yilma, T. D. (2005). Vaccinia viruses with a serpin gene deletion and expressing IFN-{gamma} induce potent immune responses without detectable replication in vivo. Proc. Natl. Acad. Sci. USA 102: 2940-2945 [Abstract] [Full Text]  
  • Chaudhri, G., Panchanathan, V., Buller, R. M. L., van den Eertwegh, A. J. M., Claassen, E., Zhou, J., de Chazal, R., Laman, J. D., Karupiah, G. (2004). Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc. Natl. Acad. Sci. USA 101: 9057-9062 [Abstract] [Full Text]  
  • Nathaniel, R., MacNeill, A. L., Wang, Y.-X., Turner, P. C., Moyer, R. W. (2004). Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J. Gen. Virol. 85: 1267-1278 [Abstract] [Full Text]  
  • Legrand, F. A., Verardi, P. H., Jones, L. A., Chan, K. S., Peng, Y., Yilma, T. D. (2004). Induction of Potent Humoral and Cell-Mediated Immune Responses by Attenuated Vaccinia Virus Vectors with Deleted Serpin Genes. J. Virol. 78: 2770-2779 [Abstract] [Full Text]  
  • Johnston, J. B., McFadden, G. (2003). Poxvirus Immunomodulatory Strategies: Current Perspectives. J. Virol. 77: 6093-6100 [Full Text]  
  • Symons, J. A., Tscharke, D. C., Price, N., Smith, G. L. (2002). A study of the vaccinia virus interferon-{gamma} receptor and its contribution to virus virulence. J. Gen. Virol. 83: 1953-1964 [Abstract] [Full Text]  
  • Alcami, A., Smith, G. L. (2002). The vaccinia virus soluble interferon-{gamma} receptor is a homodimer. J. Gen. Virol. 83: 545-549 [Abstract] [Full Text]  
  • Smith, V. P., Alcami, A. (2002). Inhibition of Interferons by Ectromelia Virus. J. Virol. 76: 1124-1134 [Abstract] [Full Text]  
  • Verardi, P. H., Aziz, F. H., Ahmad, S., Jones, L. A., Beyene, B., Ngotho, R. N., Wamwayi, H. M., Yesus, M. G., Egziabher, B. G., Yilma, T. D. (2002). Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins. J. Virol. 76: 484-491 [Abstract] [Full Text]